Duke Clinical Research Institute (DCRI) inked a clinical trials collaborative deal with the world’s largest privately held drug company—Boehringer Ingelheim—and publicly traded Eli Lilly (NYSE:LLY) to launch the EMPACT-MI (EMPAgliflozin for the prevention of Chronic...
Myocardial Infarction
Category
Controversy over Heart Attack Study Data and Recommendations Causes Fallout
The definition of what constitutes a heart attack, also known as myocardial infarction (MI), and the data points used to create a best practices report for cardiac patient care has created a storm of controversy in the European cardiac field. The Clinical StudyThe...
Montreal Heart Institute Reveals Possibilities to Reduce Cardiovascular Risk with Low Cost Drug
The Montreal Heart Institute (MHI) announced results from the COLchicine Cardiovascular Outcomes Trial (COLCOT). By combining colchicine to a placebo on top of standard of care in preventing ischemic cardiovascular events in patients who recently suffered from...